TRDA Entrada Therapeutics Inc.

• $1.6M bought by 2 insiders
• $13.8M sold by 4 insiders outside a trading plan
• $1.3M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Mpm Bioventures 2018, L.P. 10% owner, +2 joint filers
   Sale
   $1.9M 259,837 shares at $7.33 6.3% of stake
   Traded Sep 4–9 Filed Sep 9
   ↗
3. Mpm Bioventures 2018, L.P. 10% owner, +2 joint filers
   Sale
   $617K 86,482 shares at $7.14 2% of stake
   Traded Sep 1–3 Filed Sep 3
   ↗
4. Mpm Bioventures 2018, L.P. 10% owner, +2 joint filers
   Sale
   $616K 86,914 shares at $7.08 2% of stake
   Traded Aug 27–31 Filed Aug 31
   ↗
5. MPM BioVentures 2014, L.P. 10% owner, +9 joint filers
   Sale
   $462K 62,714 shares at $7.36 1.4% of stake
   Traded Aug 24–26 Filed Aug 26
   ↗
6. Kush Parmar Director
   Sale
   $1.1M 155,255 shares at $6.95 5.5% of stake
   Traded Aug 6–10 Filed Aug 10
   ↗
7. 5AM Ventures V, L.P. 10% owner, +5 joint filers
   Sale
   $432K 62,811 shares at $6.88 2.2% of stake
   Traded Aug 6–7 Filed Aug 10
   ↗
8. Kush Parmar Director
   Sale
   $807K 116,474 shares at $6.93 3.9% of stake
   Traded Jul 30–31 Filed Aug 3
   ↗
9. Bernhardt G Zeiher Director
   Buy
   $29K 5,000 shares at $5.86 New stake
   Traded May 20 Filed May 21
   ↗
10. Natarajan Sethuraman President, Research & Develop.
    Planned sale
    $399K 25,907 shares at $15.39 11% of stake
    Traded May 4 Filed May 4
    ↗
11. Nathan J Dowden COO
    Planned sale
    $230K 15,000 shares at $15.33 7% of stake
    Traded May 4 Filed May 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 share withholdings for taxes, 4 stock grants, and 1 option exercise.